The medicinal use of cannabis in the UK: results of a nationwide survey

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International journal of clinical practice

• Publication date

  2004-10-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1742-1241.2004.00271.xPMID 15857325
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patterns of Marijuana Use Among Patients With HIV/AIDS Followed in a Public Health Care Setting

  2004cited by this paper
• Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.

  2003cited by this paper
• Cannabis use for chronic non‐cancer pain: results of a prospective survey

  2003influential reference
• Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.

  2003cited by this paper
• Cannabis Use by Persons Living with HIV/AIDS: Patterns and Prevalence of Use

  2003cited by this paper
• Cannabis Use as Described by People with Multiple Sclerosis

  2003cited by this paper
• Cannabis for chronic pain: case series and implications for clinicians.

  2002cited by this paper
• A dramatic response to inhaled cannabis in a woman with central thalamic pain and dystonia.

  2002cited by this paper
• Marijuana Use in HIV-Positive and AIDS Patients

  2001cited by this paper
• Sex differences in antinociceptive and motoric effects of cannabinoids.

  2001cited by this paper
• Mary-Jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents.

  2001cited by this paper
• Marijuana for the management of proximal mytonic myopathy.

  2001cited by this paper
• Self-reported medical use of marijuana: a survey of the general population.

  2000influential reference
• Who is Using Cannabis as a Medicine and Why: An Exploratory Study

  2000cited by this paper
• Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors

  1999cited by this paper
• [Familial Mediterranean fever].

  1998cited by this paper
• The perceived effects of smoked cannabis on patients with multiple sclerosis.

  1997cited by this paper
• Pain relief with oral cannabinoids in familial Mediterranean fever

  1997cited by this paper

• UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Complex Regional Pain Syndrome

  2025cites this paper
• Cannabis use disorders - new challenges for health systems in West Africa: a narrative review

  2025cites this paper
• Patterns of medicinal cannabis prescriptions in diverse patient populations: a retrospective analysis

  2025cites this paper
• The differential effects of medicinal cannabis on mental health: A systematic review.

  2025cites this paper
• Prevalence and Characteristics of Medicinal Cannabis Use among Chronic Pain Patients; A Post- Legalization Study in a Tertiary Care Setting in Thailand

  2024cites this paper
• An early economic analysis of medical cannabis for the treatment of chronic pain

  2024cites this paper
• Illicit Cannabis Use to Self-Treat Chronic Health Conditions in the United Kingdom: Cross-Sectional Study

  2024cites this paper
• Simultaneous Cannabis and Alcohol Use among Medical Cannabis Patients

  2024cites this paper
• Exploring medicinal use of low-THC cannabis products - Comparing experienced effects and side-effects between CBD-oil-only users to users of high-THC cannabis products

  2024cites this paper
• Comparison of decarboxylation rates of acidic cannabinoids between secretory cavity contents and air-dried inflorescence extracts in Cannabis sativa cv. ‘Cherry Wine’

  2024cites this paper
• The role of personality traits on self-medicated cannabis in rheumatoid arthritis patients: A multivariable analysis

  2023cites this paper
• Differential regulation of Cav3.2 and Cav2.2 calcium channels by CB1 receptors and cannabidiol

  2023cites this paper
• Symptom severity is a major determinant of cannabis-based products use among people with multiple sclerosis.

  2023cites this paper
• Topical cannabidiol is well tolerated in individuals with a history of elite physical performance and chronic lower extremity pain

  2023cites this paper
• Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions

  2023cites this paper
• Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence

  2023cites this paper
• Cannabis Use: A New Risk Behaviour Among Adults With Congenital Heart Disease

  2023cites this paper
• The evolving culture of medical cannabis in Canada for the management of chronic pain

  2023cites this paper
• Medical Cannabis Use Among Canadian Veterans and Non-Veterans: A National Survey

  2023cites this paper
• Negotiating Ambiguous Substance Use: UK newspaper representations of self-prescribing medicinal cannabis use in the 1990s

  2022cites this paper
• Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies

  2022cites this paper
• The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms

  2022cites this paper
• The Quebec Cannabis Registry: Investigating the Safety and Effectiveness of Medical Cannabis

  2022cites this paper
• Rapid treatments for depression: Endocannabinoid system as a therapeutic target.

  2022cites this paper
• Hippocampal CB1 Receptor mediates antidepressant-like effect of Synthetic Cannabinoid-HU210 in Acute Despair Reaction model in mice.

  2022cites this paper
• Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance Use

  2022cites this paper
• With Medicine in Mind? Exploring the Relevance of Having Recreational Experience When Becoming a Medicinal Cannabis User

  2022cites this paper
• Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review

  2022cites this paper
• Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey

  2022cites this paper
• Cannabis Use and Mental Health: Paradoxes of Medicalization

  2022cites this paper
• Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study

  2022cites this paper
• Healthcare professionals' perspectives on the use of medicinal cannabis to manage chronic pain: A systematic search and narrative review

  2022cites this paper
• Cannabis Dosing and Administration for Sleep: A Systematic Review.

  2022cites this paper
• Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada

  2021cites this paper
• Metabolomic Analysis of Cannabinoid and Essential Oil Profiles in Different Hemp (Cannabis sativa L.) Phenotypes

  2021cites this paper
• Therapeutic Potential for Cannabinoids in Sports Medicine: Current Literature Review

  2021cites this paper
• Beyond the high: Mapping patterns of use and motives for use of cannabis as medicine

  2021influential citation
• Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample

  2021cites this paper
• Current controversies in medical cannabis: recent developments in human clinical applications and potential therapeutics.

  2021cites this paper
• Perception and Belief on Cannabinoids: A Comparative Study of Rheumatology Patients and Primary Care Physicians on the Use of Cannabinoids for Pain Management

  2021cites this paper
• Patterns of Medical Cannabis Use among Patients Diagnosed with Multiple Sclerosis.

  2021cites this paper
• Assessment of Medical Cannabis in Patients With Osteoarthritis of the Thumb Basal Joint.

  2021cites this paper
• Reasons for cannabis use during pregnancy and lactation: a qualitative study

  2021cites this paper
• Small and Transient Effect of Cannabis Oil for Osteoarthritis-Related Joint Pain: A Case Report.

  2021cites this paper
• Real World Evidence in Medical Cannabis Research

  2021cites this paper
• Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses

  2021cites this paper
• Overview: Exploring the onto-politics of cannabis

  2021cites this paper
• Antinociceptive and Anti-Inflammatory Properties of Cannabidiol Alone and in Combination with Standardized Bioflavonoid Composition

  2021cites this paper
• Cannabis Use among Older Persons with Arthritis, Cancer and Multiple Sclerosis: Are We Comparing Apples and Oranges?

  2021influential citation
• Medicinal Cannabis Users Downplaying and Shifting Stigma: Articulations of the ‘Natural’, of What Is/Is Not a ‘Drug’ and Oppositions with ‘Chemical’ Substances

  2020cites this paper
• Cannabis for medical and scientific purposes: the Colombian landscape

  2020cites this paper
• The pharmacokinetics, efficacy, and safety of a novel selective‐dose cannabis inhaler in patients with chronic pain: A randomized, double‐blinded, placebo‐controlled trial

  2020cites this paper
• The endocannabinoid signaling pathway as an emerging target in pharmacotherapy, earmarking mitigation of destructive events in rheumatoid arthritis.

  2020cites this paper
• Medical Marijuana and Other Cannabinoids

  2020cites this paper
• Opioids and Cannabinoids for Osteoarthritis: Either, Both, or Neither

  2020cites this paper
• Cannabis use in people with multiple sclerosis and spasticity: A cross-sectional analysis.

  2020cites this paper
• Cannabidiol and refractory epilepsy: parental and caregiver perspectives of participation in a compassionate access scheme

  2020cites this paper
• Knowledge and perspectives about the use of cannabis as a medicine: a mixed methods observational study in a cohort of New Zealand general practice patients.

  2020cites this paper
• Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions

  2020cites this paper
• Cannabis Use in Hospitalized Patients with Chronic Pain

  2020cites this paper
• Influences of phytocannabinoids on drug-drug interactions and their clinical implications.

  2020cites this paper
• Medical cannabis and cannabinoids in rheumatology: where are we now?

  2019cites this paper
• Cannabis use under prohibitionism – the interplay between motives, contexts and subjects

  2019cites this paper
• Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: A population-based cohort study.

  2019cites this paper
• Pain and Cannabis Markets

  2019cites this paper
• Cannabis for musculoskeletal pain and arthritis: Evidence is needed.

  2019cites this paper
• Age related differences in cannabis use and subjective effects in a large population-based survey of adult athletes

  2019cites this paper
• Cannabis in Patients with Liver Disease; A Concise Review of Recent Data

  2019cites this paper
• Examining the blurred boundaries between medical and recreational cannabis – results from an international study of small-scale cannabis cultivators

  2019cites this paper
• Le cannabis dans les douleurs musculosquelettiques et articulaires : des preuves sont nécessaires

  2019cites this paper
• OPINION Joints for joints: cannabinoids in the treatment of rheumatoid arthritis

  2019cites this paper
• Illegal cannabis use is common among Danes with multiple sclerosis.

  2019cites this paper
• Joints for joints: cannabinoids in the treatment of rheumatoid arthritis

  2019cites this paper
• Is cannabis use associated with tobacco cessation outcome? An observational cohort study in primary care.

  2019cites this paper
• Pharmacies as potential providers of harm reduction services: A preliminary online survey

  2018cites this paper
• Chronic pain and cannabinoids. Great expectations or a christmas carol

  2018cites this paper
• Cannabinoids for the treatment of rheumatic diseases — where do we stand?

  2018cites this paper
• Rates of cannabis use in patients with cancer.

  2018cites this paper
• Patient characteristics from a medical cannabis provider

  2018cites this paper
• Cannabis use in people with Multiple Sclerosis : the highway to lower disability?

  2018cites this paper
• Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain

  2018cites this paper
• ‘You can’t stand on a corner and talk about it …’: Medicinal cannabis use, impression management and the analytical status of interviews

  2018cites this paper
• Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015.

  2018cites this paper
• Primary Causes of Hospitalizations and Procedures, Predictors of In-hospital Mortality, and Trends in Cardiovascular and Cerebrovascular Events Among Recreational Marijuana Users: A Five-year Nationwide Inpatient Assessment in the United States

  2018cites this paper
• A profile of medical cannabis users residing in Canada and the United Kingdom: Accounting for policy and experience

  2018cites this paper
• Cannabis Sativa Increases Seizure Severity and Brain Lipid Peroxidation in Pentylenetetrazole-Induced Kindling in Rats

  2018cites this paper
• Do characteristics of marijuana use correspond to overall health levels for medical marijuana patients?

  2018cites this paper
• Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis

  2018cites this paper
• Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer.

  2018cites this paper
• Symptom clusters in patient-reported outcomes of medical cannabis patients

  2018cites this paper
• Cannabis sativa Increases Seizure Severity and Brain Lipid Peroxidation in Pentylenetetrazole-Induced Kindling in Rats

  2018cites this paper
• The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.

  2017influential citation
• Medical use of cannabis in Switzerland: analysis of approved exceptional licences.

  2017cites this paper
• A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.

  2017cites this paper
• Chronic pain patients' perspectives of medical cannabis

  2017cites this paper
• Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation.

  2017cites this paper
• Sex Differences in the Anxiety Effects of Cannabinoids

  2017cites this paper
• Cannabis and epilepsy: An ancient treatment returns to the fore.

  2017cites this paper
• 4 Cannabinoids and Neuropathic Pain

  2017cites this paper
• Endocannabinoids in arthritis: current views and perspective

  2017cites this paper